Management of Genitourinary Syndrome of Menopause in Korean Breast Cancer Survivors by Fractional CO 2 Laser Treatment
Yonsei Medical Journal · 2026
DOI: 10.3349/ymj.2025.0161 ↗Kurz gefasst
Fachartikel in der Zeitschrift Yonsei Medical Journal, 2026. Verfasst von Youn-Jee Chung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. Hauptthemen laut MEDLINE: Breast Neoplasms, Lasers, Gas, Menopause, Female Urogenital Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
PURPOSE: Many breast cancer patients experience genitourinary syndrome of menopause (GSM) symptoms. Concerns about systemic absorption limit the use of local estrogen therapy, and clinicians are often hesitant to prescribe it to breast cancer survivors. Therefore, other treatment options are essential. The aim of this study was to examine the safety and effectiveness of fractional CO₂ laser treatment in breast cancer survivors experiencing GSM. MATERIALS AND METHODS: Each woman received three fractional CO₂ treatments at 4-week intervals between sessions: baseline (V1), 4-week follow-up (V2), 8-week follow-up (V3), and a final follow-up at 12 weeks (V4). Breast cancer survivors who had one or more symptoms related to GSM qualified for inclusion in this study. Severity of symptoms was assessed with a visual analog scale (VAS) at baseline and every follow-up visit. We also measured GSM objectively using the vaginal health index score (VHIS) at every visit. At V4, patients evaluated their satisfaction with laser therapy using a 5-point Likert scale. RESULTS: Twenty-four women were included in the study. Almost all symptoms showed improvement based on mean VAS score after treatment. Vaginal dryness and urgency improved after the second treatment. After completion of all treatments, all symptoms except frequency showed improvement. VHIS increased significantly after completion of laser treatment (8.5±3.1 at baseline vs. 16.2±2.9 at V4; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Department of Obstetrics and Gynecology, Grace Women's Hospital, Goyang, Korea.
- Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. jaeyen77@nate.com.
ORCID-Profile: Youn-Jee Chung, Minji Ko, Jung Yoon Park, Mee-Ran Kim, Jae-Yen Song
Förderung
- National Research Foundation of Korea
Zitieren
APA
Chung, Y. J., Ko, M., Park, J. Y., Kim, M. R., & Song, J. Y. (2026). Management of Genitourinary Syndrome of Menopause in Korean Breast Cancer Survivors by Fractional CO 2 Laser Treatment. Yonsei Medical Journal. https://doi.org/10.3349/ymj.2025.0161
Vancouver
Chung YJ, Ko M, Park JY, Kim MR, Song JY. Management of Genitourinary Syndrome of Menopause in Korean Breast Cancer Survivors by Fractional CO 2 Laser Treatment. Yonsei Medical Journal. 2026. doi:10.3349/ymj.2025.0161
BibTeX
@article{Chung2026,
author = {Chung, Youn-Jee and Ko, Minji and Park, Jung Yoon and Kim, Mee-Ran and Song, Jae-Yen},
title = {Management of Genitourinary Syndrome of Menopause in Korean Breast Cancer Survivors by Fractional CO 2 Laser Treatment},
journal = {Yonsei Medical Journal},
year = {2026},
doi = {10.3349/ymj.2025.0161}
}
EUVIMED